alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IB 

Union Calendar No. 339 

115TH CONGRESS 

1ST SESSION H. R. 1733 

[Report No. 115–457] 

To direct the Secretary of Energy to review and update a report on the 

energy and environmental benefits of the re-refining of used lubricating oil. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 27, 2017 

Mrs. BROOKS of Indiana (for herself and Mr. KENNEDY) introduced the 

following bill; which was referred to the Committee on Energy and Commerce 

DECEMBER 11, 2017 

Additional sponsors: Mr. CRAMER, Mr. BUCSHON, Mrs. BEATTY, Mr. TONKO, 

Mr. MOULTON, Mr. LIPINSKI, Mr. SENSENBRENNER, Mr. ROSKAM, Ms. 

TSONGAS, Ms. LOFGREN, Mr. LUETKEMEYER, Mr. SCHRADER, and Mr. 

SAM JOHNSON of Texas 

DECEMBER 11, 2017 

Committed to the Committee of the Whole House on the State of the Union 

and ordered to be printed 


ethrower on DSK3G9T082PROD with BILLS
2 

•HR 1733 RH

A BILL 

To direct the Secretary of Energy to review and update 

a report on the energy and environmental benefits of 

the re-refining of used lubricating oil. 


ethrower on DSK3G9T082PROD with BILLS
3 

•HR 1733 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ENERGY SAVINGS FROM LUBRICATING OIL. 

4 Not later than one year after the date of enactment 

5 of this Act, the Secretary of Energy, in cooperation with 

6 the Administrator of the Environmental Protection Agen7 cy and the Director of the Office of Management and 

8 Budget, shall— 

9 (1) review and update the report prepared pur10 suant to section 1838 of the Energy Policy Act of 

11 2005; 

12 (2) after consultation with relevant Federal, 

13 State, and local agencies and affected industry and 

14 stakeholder groups, update data that was used in 

15 preparing that report; and 

16 (3) prepare and submit to Congress a coordi17 nated Federal strategy to increase the beneficial 

18 reuse of used lubricating oil, that— 

19 (A) is consistent with national policy as es20 tablished pursuant to section 2 of the Used Oil 

21 Recycling Act of 1980 (Public Law 96–463); 

22 and 

23 (B) addresses measures needed to— 

24 (i) increase the responsible collection 

25 of used oil; 


ethrower on DSK3G9T082PROD with BILLS
4 

•HR 1733 RH

1 (ii) disseminate public information 

2 concerning sustainable reuse options for 

3 used oil; and 

4 (iii) promote sustainable reuse of used 

5 oil by Federal agencies, recipients of Fed6 eral grant funds, entities contracting with 

7 the Federal Government, and the general 

8 public. 


ethrower on DSK3G9T082PROD with BILLS

ethrower on DSK3G9T082PROD with BILLS
Union Calendar No. 339 

115TH CONGRESS 

1ST SESSION H. R. 1733 

[Report No. 115–457] 

A BILL 

To direct the Secretary of Energy to review and upbenefits of the re-refining of used lubricating oil. date a report on the energy and environmental 

DECEMBER 11, 2017 

Committed to the Committee of the Whole House on the 

State of the Union and ordered to be printed 


ethrower on DSK3G9T082PROD with BILLS
---

---

Exhibit 15.2

# CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by
reference in Registration Statement on Form F-3 (Registration No. 333-116232) of Prana
Biotechnology Limited (the Company) of our report dated September 29, 2006
(June 18, 2007 as to the effects of the restatement discussed in Note 27) (which report
expresses an unqualified opinion and includes explanatory paragraphs relating to going
concern discussed in Note 1 and the restatement discussed in Note 27) relating to the
Companys consolidated financial statements for the year ended June 30, 2006,
appearing in this Annual Report on Form 20-F of the Company for the fiscal year ended June
30, 2008.

/s/ Deloitte Touche
Tohmatsu

DELOITTE TOUCHE TOHMATSU

Melbourne, Victoria,
Australia  September 25, 2008



---

---
Exhibit 32.1

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and
Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), John P. McLaughlin, President and Chief Executive Officer of Corgentech Inc., a
Delaware corporation (the "Company") hereby certifies that, to the best of his knowledge, as follows:

The
Company's Annual Report on Form 10-K for the period ended December 31, 2003, to which this Certification is attached as Exhibit 32.1 (the
"Periodic Report") fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended, and that the
information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

IN WITNESS WHEREOF, the undersigned has set his hand hereto as of this 29th day of March, 2004.

| | By: |  | /s/JOHN P. MCLAUGHLINJohn P. McLaughlin
President and Chief Executive Officer
(Principal Executive Officer)
| | --- |  | -----------------------------------------------------------------------------------------------------------

A signed original of this written statement required by Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and
Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), has been provided to Corgentech Inc. and will be retained by Corgentech Inc. and
furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies the Form 10-K to which it relates, is not deemed filed with the
Securities and Exchange Commission and is not to be incorporated by reference into any filing of Corgentech Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of
1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.

---

QuickLinks
No: I-19-011 April 23, 2019

Contact: Diane Screnci, 610-337-5330

 Neil Sheehan, 610-337-5331

NRC to Hold Public Open House to Discuss

2018 Performance of Calvert Cliffs Nuclear Power Plant

Nuclear Regulatory Commission staff will discuss the 2018 safety performance of the 

Calvert Cliffs nuclear power plant, operated by Exelon, during an open house on April 30 in Prince 

Frederick, Md.

The open house, to be held at the SpringHill Suites Hotel, 75 Sherry Lane, Prince Frederick,

will run from 6-7 p.m. NRC employees responsible for plant inspections, including the resident 

inspectors based full-time at the site, will be available to discuss the plant’s performance.

Calvert Cliffs operated safely during 2018. At the end of the year, all inspection findings and 

performance indicators were no greater than green, or of very low safety significance. As a result, 

the plant remains under the NRC’s normal level of oversight, which entails thousands of hours of 

inspection each year.

The NRC Reactor Oversight Process uses color-coded inspection findings and indicators to 

measure plant performance. The colors start at green and increase to white, yellow or red, 

commensurate with the safety significance of the issues involved. Inspection findings or 

performance indicators with more than very low safety significance trigger increased NRC 

oversight.

Inspections are performed by two NRC resident inspectors and inspection specialists from 

the agency’s Region I Office.

The annual assessment letter for Calvert Cliffs, as well as the notice for the open house, are 

available on the NRC website. Current performance information for Unit 1 and Unit 2 is also 

available.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of General Medical Sciences Special Emphasis Panel; Review of R24 Legacy.                    

*Date:*                         February 26, 2015.                    

*Time:*                         12 p.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications                    

*Place:*                         National Institutes of Health, Natcher Building, 45 Center Drive, Room 3An.12K, Bethesda, MD 20892, (Telephone Conference Call).                    

*Contact Person:*                         Nina Sidorova, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3An.12K, Bethesda, MD 20892, 301-402-2783,                         *sidorova@nigms.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS)

Dated: January 21, 2015.

Melanie J. Gray,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2015-01368 Filed 1-26-15; 8:45 am]

BILLING CODE 4140-01-P
I 

115TH CONGRESS 

1ST SESSION H. R. 1624 

To require the appropriate Federal banking agencies to treat certain 

municipal obligations as level 2A liquid assets, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 20, 2017 

Mr. MESSER (for himself, Mrs. CAROLYN B. MALONEY of New York, Mr. 

HULTGREN, Mr. MEEKS, Ms. KELLY of Illinois, Ms. SEWELL of Alabama, Ms. SINEMA, Mr. KING of New York, Ms. NORTON, Ms. MOORE, 

Mr. POLIQUIN, Mr. VEASEY, Mr. SHERMAN, and Mr. KIND) introduced 

the following bill; which was referred to the Committee on Financial Services 

A BILL 

To require the appropriate Federal banking agencies to treat 

certain municipal obligations as level 2A liquid assets, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Municipal Finance 

5 Support Act of 2017’’. 


lotter on DSK5VPTVN1PROD with BILLS
2 

•HR 1624 IH

1 SEC. 2. TREATMENT OF CERTAIN MUNICIPAL OBLIGA2 TIONS. 

3 (a) IN GENERAL.—Section 18 of the Federal Deposit 

4 Insurance Act (12 U.S.C. 1828) is amended— 

5 (1) by moving subsection (z) so that it appears 

6 after subsection (y); and 

7 (2) by adding at the end the following: 

8 ‘‘(aa) TREATMENT OF CERTAIN MUNICIPAL OBLIGA9 TIONS.— 

10 ‘‘(1) IN GENERAL.—For purposes of the final 

11 rule titled ‘Liquidity Coverage Ratio: Liquidity Risk 

12 Measurement Standards; Final Rule’ (79 Fed. Reg. 

13 61439; published October 10, 2014) (the ‘Final 

14 Rule’) and any other regulation which incorporates 

15 a definition of the term ‘high-quality liquid asset’, 

16 the appropriate Federal banking agencies shall treat 

17 a municipal obligation that is both liquid and readily 

18 marketable (as defined in the Final Rule) and in19 vestment grade as of the calculation date as a high20 quality liquid asset that is a level 2A liquid asset. 

21 ‘‘(2) DEFINITIONS.—For purposes of this sub22 section: 

23 ‘‘(A) INVESTMENT GRADE.—With respect 

24 to an obligation, the term ‘investment grade’ 

25 has the meaning given that term under part 1 

26 of title 12, Code of Federal Regulations. 


lotter on DSK5VPTVN1PROD with BILLS
3 

•HR 1624 IH

1 ‘‘(B) MUNICIPAL OBLIGATION.—The term 

2 ‘municipal obligation’ means an obligation of a 

3 State or any political subdivision thereof, or any 

4 agency or instrumentality of a State or any po5 litical subdivision thereof.’’. 

6 (b) AMENDMENT TO LIQUIDITY COVERAGE RATIO

7 REGULATIONS.—Not later than the end of the 3-month 

8 period beginning on the date of the enactment of this Act, 

9 the Federal Deposit Insurance Corporation, the Board of 

10 Governors of the Federal Reserve System, and the Comp11 troller of the Currency shall amend the final rule titled 

12 ‘‘Liquidity Coverage Ratio: Liquidity Risk Measurement 

13 Standards; Final Rule’’ (79 Fed. Reg. 61439; published 

14 October 10, 2014) to implement the amendments made 

15 by this Act. 

Æ 


lotter on DSK5VPTVN1PROD with BILLS
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-392]
 ACTION: Notice of registration.
 SUMMARY: Research Triangle Institute applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Research Triangle Institute registration as a manufacturer of those controlled substances.


SUPPLEMENTARY INFORMATION: By notice dated July 2, 2014, and published in the 
                    **Federal Register**
                     on July 14, 2014, 79 FR 40781, Research Triangle Institute, Kenneth S. Rehder, Ph.D., Hermann Building East Institute Drive, P.O. Box 12194, Research Triangle Park, North Carolina 27709, applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice. The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Research Triangle Institute to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.
                    ( print page 3989) Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed: Controlled
                             substance
ScheduleMarihuana (7360)
ITetrahydrocannabinols (7370)
ICocaine (9041)
II
 The company will manufacture marihuana and cocaine derivatives for use by their customers in analytical kits, reagents, and reference standards as directed by the National Institute on Drug Abuse. Dated: January 9, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator.


[FR Doc. 2015-01301 Filed 1-23-15; 8:45 am] BILLING CODE P
#### The People of the State of New York, Respondent, v Anthony A. Devivo, Appellant.

[631 NYS2d 547]

Appeal from a judgment of the County Court of Broome County (Smith, J.), rendered August 11, 1993, convicting defendant upon his plea of guilty of the crime of criminal sale of a controlled substance in the third degree.

In satisfaction of two indictments charging him with six counts of criminal sale of a controlled substance in the third degree as well as the dismissal of one charge of petit larceny, defendant pleaded guilty to one count of criminal sale of a controlled substance in the third degree and received a sentence of 3 to 9 years in prison. The record reveals that defendant has an extensive criminal record and prior probation violations. In view of this, we reject defendant’s claim that the sentence is harsh and excessive. We have considered defendant’s remaining arguments, including those contained in his *pro se*brief, and find them to be without merit.

Mercure, J. P., Crew III, Yesawich Jr., Peters and Spain, JJ., concur. Ordered that the judgment is affirmed.
### TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03

- 21

- 00173

- CV

In re MasTec North America, Inc.

ORIGINAL PROCEEDING FROM TRAVIS COUNTY

M E M O R A N D U M O P I N I O N

The petition for writ of mandamus is denied. See Tex. R. App. P. 52 .8(a). We

also l ift the stay of the trial court ’ s discovery orders.

_______________________ ___________________

Gisel a D. Triana , Justice

Before Justices Goodwin , Triana, and Kelly

Filed: Ju ly 7 , 2021
[Federal Register Volume 80, Number 18 (Wednesday, January 28, 2015)]
[Notices]
[Pages 4560-4561]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-01495]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER15-876-000]


Malaga Power, LLC; Supplemental Notice That Initial Market-Based 
Rate Filing Includes Request for Blanket Section 204 Authorization

    This is a supplemental notice in the above-referenced proceeding, 
of Malaga Power, LLC's application for market-based rate authority, 
with an accompanying rate schedule, noting that such application 
includes a request for blanket authorization, under 18 CFR part 34, of 
future issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the 
Federal

[[Page 4561]]

Energy Regulatory Commission, 888 First Street, NE., Washington, DC 
20426, in accordance with Rules 211 and 214 of the Commission's Rules 
of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone filing a 
motion to intervene or protest must serve a copy of that document on 
the Applicant.
    Notice is hereby given that the deadline for filing protests with 
regard to the applicant's request for blanket authorization, under 18 
CFR part 34, of future issuances of securities and assumptions of 
liability is February 9, 2015.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet 
access who will eFile a document and/or be listed as a contact for an 
intervenor must create and validate an eRegistration account using the 
eRegistration link. Select the eFiling link to log on and submit the 
intervention or protests.
    Persons unable to file electronically should submit an original and 
5 copies of the intervention or protest to the Federal Energy 
Regulatory Commission, 888 First Street, NE., Washington, DC 20426.
    The filings in the above-referenced proceeding(s) are accessible in 
the Commission's eLibrary system by clicking on the appropriate link in 
the above list. They are also available for review in the Commission's 
Public Reference Room in Washington, DC. There is an eSubscription link 
on the Web site that enables subscribers to receive email notification 
when a document is added to a subscribed docket(s). For assistance with 
any FERC Online service, please email <a href="/cdn-cgi/l/email-protection#f1b7b4a3b2be9f9d989f94a28481819e8385b197948392df969e87"><span class="__cf_email__" data-cfemail="b5f3f0e7f6fadbd9dcdbd0e6c0c5c5dac7c1f5d3d0c7d69bd2dac3">[email protected]</span></a>. or 
call (866) 208-3676 (toll free). For TTY, call (202) 502-8659.

    Dated: January 20, 2015.
Kimberly D. Bose,
Secretary.
[FR Doc. 2015-01495 Filed 1-27-15; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANESOXLEY ACT OF 2002



In connection with the Annual Report of Mykrolis Corporation (the Company) on Form 10K for the year ended December 31, 2004 as filed with the Securities
and Exchange Commission on the date hereof (the Report), We, Gideon Argov, Chief Executive Officer of the Company and Bertrand Loy, Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as
adopted pursuant to §906 of the SarbanesOxley Act of 2002, that:



|1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|-- | ---------------------------------------------------------------------------------------------------------------------



|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                       
|-----------------------
|/s/ Gideon Argov       
|Gideon Argov           
|Chief Executive Officer

March 11, 2005



|                                          
|------------------------------------------
|/s/ Bertrand Loy                          
|Bertrand Loy                              
|Vice President and Chief Financial Officer
|March 11, 2005                            



Exhibit Volume Page 84 of 84